Skip to main content
OpenTrials

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,144 public trials 77 recruiting studies
Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4

NCT01686789

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +15 more
Locations
  • King Faisal Specialist Hospital & Research Centre Riyadh, Saudi Arabia
  • King Abdulaziz Medical City Riyadh, Saudi Arabia
  • King Khaled University Hospital Riyadh, Saudi Arabia
View Trial Details
Completed

ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.

NCT00077636

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Birmingham, Alabama, United States
  • Mobile, Alabama, United States
  • Anchorage, Alaska, United States
  • Phoenix, Arizona, United States
View all 132 locations
View Trial Details
Completed

A Study to Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With Simeprevir

NCT02103699

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Phoenix, Arizona, United States
  • Bakersfield, California, United States
  • Beverly Hills, California, United States
  • Los Angeles, California, United States
View all 32 locations
View Trial Details
Completed

A Study of Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment

NCT00537407

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • Scripps Clinic Liver Disease Research Center La Jolla, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Miami Center for Liver Diseases Miami, Florida, United States
  • The Johns Hopkins University School of Medicine Baltimore, Maryland, United States
View Trial Details
Completed

A Study of Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients

NCT00854802

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • UZ Gent Ghent, Belgium
  • C.H.U - Hôpital Henri-Mondor Créteil, France
  • C.H.U de Lyon Hôpital de l'Hôtel Dieu Lyon, France
View all 40 locations
View Trial Details
Completed

Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2

NCT01728324

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • 1241.36.00016 Boehringer Ingelheim Investigational Site North Little Rock, Arkansas, United States
  • 1241.36.00020 Boehringer Ingelheim Investigational Site Anaheim, California, United States
  • 1241.36.00005 Boehringer Ingelheim Investigational Site Bakersfield, California, United States
  • 1241.36.00009 Boehringer Ingelheim Investigational Site La Jolla, California, United States
View all 109 locations
View Trial Details
Completed

Epidemiological Study to Evaluate the Management of Patients With Chronic Hepatitis C and Previous Treatment Failure

NCT01033045

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • H. de Antequera Antequera, Andalusia, Spain
  • H. Puerta de Mar Cadiz, Andalusia, Spain
  • H. Puerto Real Cadiz, Andalusia, Spain
  • H. Vírgen de las Nieves Granada, Andalusia, Spain
View all 104 locations
View Trial Details

Related conditions